JUBILANT PHARMOVA Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA Quarterly Results    (JUBOL)

Here are the latest quarterly results of JUBILANT PHARMOVA . For more details, see the JUBILANT PHARMOVA financial fact sheet and JUBILANT PHARMOVA share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

JUBILANT PHARMOVA Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
3
Jun-21
*
3
Sep-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m23,15215,68511,56115,91417,71315,79816,34716,575 
Other income Rs m60173393536673945 
Turnover Rs m23,21215,85811,60015,94817,74915,86516,38516,619 
Expenses Rs m18,07811,3089,76812,41612,78612,05212,59413,180 
Gross profit Rs m4,7284,3771,7933,4984,8193,6433,7523,395 
Depreciation Rs m1,135981817851959862880998 
Interest Rs m720470479465464433346347 
Profit before tax Rs m2,9333,1005362,2173,4322,4142,5652,094 
Tax Rs m8999771827481,212831860654 
Profit after tax Rs m2,0342,1233541,4692,2201,5831,7051,440 
Gross profit margin %20.427.915.522.027.223.123.020.5 
Effective tax rate %30.731.534.033.735.334.433.531.2 
Net profit margin %8.813.53.19.212.510.010.48.7 
Diluted EPS Rs 12.8 13.3 2.2 9.2 13.9 9.9 10.7 9.0  
Diluted EPS (TTM) Rs 33.7 53.4 44.0 37.5 38.7 35.3 43.8 43.6  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

Read: JUBILANT PHARMOVA 4QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   VIVANZA BIOSCIENCES  SYNGENE INTERNATIONAL  NURECA  ALKEM LABORATORIES  SWAGRUHA INFRA  

Compare JUBILANT PHARMOVA With:   VIVANZA BIOSCIENCES  SYNGENE INTERNATIONAL  NURECA  ALKEM LABORATORIES  SWAGRUHA INFRA  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Slumped 1,688 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended deep in the red.

Views on news

JUBILANT PHARMOVA 2020-21 Annual Report Analysis (Annual Result Update)

Nov 8, 2021 | Updated on Nov 8, 2021

Here's an analysis of the annual report of JUBILANT PHARMOVA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT PHARMOVA . Also includes updates on the valuation of JUBILANT PHARMOVA .

Jubilant Pharmova Drops 6% on Weak March Quarter Numbers (Views On News)

Jun 8, 2021

Here's a rundown on the latest quarterly results of Jubilant Pharmova.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

How to Hit Rs 100 Crore Wealth in Your Lifetime (Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Don't Sell these Stocks if the Market Falls (Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT PHARMOVA SHARE PRICE


Nov 26, 2021 (Close)

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA 5-YR ANALYSIS

COMPARE JUBILANT PHARMOVA WITH

MARKET STATS